Loading…
First COVID-19 wave in the province of Bergamo, Italy: epidemiological and clinical characteristics, outcome and management of the first hospitalized patients
Northern Italy was the first European country affected by the spread of the SARS-CoV-2, with the epicenter in the province of Bergamo. This study aims to analyze the characteristics of patients who experienced more severe symptoms during the first wave of COVID-19 pandemic. We retrospectively collec...
Saved in:
Published in: | BMC infectious diseases 2024-01, Vol.24 (1), p.151-12, Article 151 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c583t-ca5a59fd3fc5c63fba572fcd68e4fdfbfdf6548ee4d81e8b2236cc31fd32c4183 |
container_end_page | 12 |
container_issue | 1 |
container_start_page | 151 |
container_title | BMC infectious diseases |
container_volume | 24 |
creator | Donida, Bianca Maria Pirola, Flavia Simonetta Opizzi, Roberto Assembergs, Peter |
description | Northern Italy was the first European country affected by the spread of the SARS-CoV-2, with the epicenter in the province of Bergamo.
This study aims to analyze the characteristics of patients who experienced more severe symptoms during the first wave of COVID-19 pandemic.
We retrospectively collected epidemiological and clinical data on patients with laboratory-confirmed wild-type SARS-CoV-2 infection who were admitted to the "ASST Bergamo Ovest" hospital between February 21 and May 31, 2020.
A total of seven hundred twenty-three inpatients met the eligible criteria and were included in the study cohort. Among the inpatients who survived, the average hospital length of stay was more than two weeks, with some lasting up to three months. Among the 281 non-survivors, death occurred in 50% within five days. Survivors were those whose first aid operators recorded higher oxygen saturation levels at home. The request for first aid assistance came more than one week after symptom onset, within three days in 10% of cases.
In similar future scenarios, based on our data, if we aim to enhance the survival rate, we need to improve the territorial healthcare assistance and admit to hospitals only those patients who are at risk of severe illness requiring specialized and urgent interventions within two, three, or, at most, five days from the onset of symptoms. This implies that the crucial factor is, has been, and will be the ability of a healthcare system to react promptly in its entirety within a few days. |
doi_str_mv | 10.1186/s12879-024-09034-4 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_98af8fd200f645158b2038ad96742d92</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A782197899</galeid><doaj_id>oai_doaj_org_article_98af8fd200f645158b2038ad96742d92</doaj_id><sourcerecordid>A782197899</sourcerecordid><originalsourceid>FETCH-LOGICAL-c583t-ca5a59fd3fc5c63fba572fcd68e4fdfbfdf6548ee4d81e8b2236cc31fd32c4183</originalsourceid><addsrcrecordid>eNqNkttu1DAQhiMEoqXwAlwgS9yA1BSfkti9QWWhsFKllTj01vL6kHWVxMH2LpSH4VlxdkvpIi5QFNmefPNPZvwXxVMETxBi9auIMGt4CTEtIYeElvRecYhog0pMCL1_Z39QPIrxCkLUMMwfFgckLw3G9LD4ee5CTGC2uJy_LREH3-TGADeAtDJgDH7jBmWAt-CNCa3s_TGYJ9ldnwIzOm165zvfOiU7IAcNVOeG7UGtZJAqmeBicioeA79OyvdmS_VykK3pzZAm3amO3f7CysfRZXH3w2gwyuQyER8XD6zsonlysx4VX87ffZ59KC8W7-ezs4tSVYykUslKVtxqYlWlamKXsmqwVbpmhlptl_mtK8qMoZohw5YYk1opgnIGVhQxclTMd7rayysxBtfLcC28dGIb8KEVMuReOiM4k5ZZjSG0Na1QldUgYVLzuqFYc5y1Xu-0xvWyN1rlPoLs9kT3vwxuJVq_EQjmayGIZoUXNwrBf12bmETvojJdJwfj11FgjhFCVYOmYs__Qq_8Ogx5VhNVVayBBP2hWpk7cIP1ubCaRMVZtgTiDeM8Uyf_oPIz3bTyg7Eux_cSXu4lZCaZ76mV6xjF_NPH_2cXl_ss3rEq-BiDsbfDQ1BM1hc764tsfbG1vpiG9uzu2G9Tfnud_AK8bf6_</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2925587031</pqid></control><display><type>article</type><title>First COVID-19 wave in the province of Bergamo, Italy: epidemiological and clinical characteristics, outcome and management of the first hospitalized patients</title><source>NCBI_PubMed Central(免费)</source><source>Publicly Available Content (ProQuest)</source><creator>Donida, Bianca Maria ; Pirola, Flavia Simonetta ; Opizzi, Roberto ; Assembergs, Peter</creator><creatorcontrib>Donida, Bianca Maria ; Pirola, Flavia Simonetta ; Opizzi, Roberto ; Assembergs, Peter</creatorcontrib><description>Northern Italy was the first European country affected by the spread of the SARS-CoV-2, with the epicenter in the province of Bergamo.
This study aims to analyze the characteristics of patients who experienced more severe symptoms during the first wave of COVID-19 pandemic.
We retrospectively collected epidemiological and clinical data on patients with laboratory-confirmed wild-type SARS-CoV-2 infection who were admitted to the "ASST Bergamo Ovest" hospital between February 21 and May 31, 2020.
A total of seven hundred twenty-three inpatients met the eligible criteria and were included in the study cohort. Among the inpatients who survived, the average hospital length of stay was more than two weeks, with some lasting up to three months. Among the 281 non-survivors, death occurred in 50% within five days. Survivors were those whose first aid operators recorded higher oxygen saturation levels at home. The request for first aid assistance came more than one week after symptom onset, within three days in 10% of cases.
In similar future scenarios, based on our data, if we aim to enhance the survival rate, we need to improve the territorial healthcare assistance and admit to hospitals only those patients who are at risk of severe illness requiring specialized and urgent interventions within two, three, or, at most, five days from the onset of symptoms. This implies that the crucial factor is, has been, and will be the ability of a healthcare system to react promptly in its entirety within a few days.</description><identifier>ISSN: 1471-2334</identifier><identifier>EISSN: 1471-2334</identifier><identifier>DOI: 10.1186/s12879-024-09034-4</identifier><identifier>PMID: 38297224</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Age ; Biomarkers ; COVID-19 ; COVID-19 - epidemiology ; COVID-19 vaccines ; Data collection ; Development and progression ; Disease transmission ; Earthquakes ; Emergency medical care ; Epidemics ; Epidemiology ; Ethics ; Evaluation ; First aid ; First aid in illness and injury ; Forecasts and trends ; Health care ; Health care reform ; Hospital patients ; Hospitals ; Humans ; Hypoxia ; Infection ; Intensive care ; Italy ; Italy - epidemiology ; Kinases ; Laboratories ; Oxygen content ; Oxygen saturation ; Pandemics ; Patient outcomes ; Patients ; Prognosis ; Public health ; Retrospective Studies ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Software ; Survival ; Viral diseases</subject><ispartof>BMC infectious diseases, 2024-01, Vol.24 (1), p.151-12, Article 151</ispartof><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c583t-ca5a59fd3fc5c63fba572fcd68e4fdfbfdf6548ee4d81e8b2236cc31fd32c4183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10829314/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2925587031?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25751,27922,27923,37010,37011,44588,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38297224$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Donida, Bianca Maria</creatorcontrib><creatorcontrib>Pirola, Flavia Simonetta</creatorcontrib><creatorcontrib>Opizzi, Roberto</creatorcontrib><creatorcontrib>Assembergs, Peter</creatorcontrib><title>First COVID-19 wave in the province of Bergamo, Italy: epidemiological and clinical characteristics, outcome and management of the first hospitalized patients</title><title>BMC infectious diseases</title><addtitle>BMC Infect Dis</addtitle><description>Northern Italy was the first European country affected by the spread of the SARS-CoV-2, with the epicenter in the province of Bergamo.
This study aims to analyze the characteristics of patients who experienced more severe symptoms during the first wave of COVID-19 pandemic.
We retrospectively collected epidemiological and clinical data on patients with laboratory-confirmed wild-type SARS-CoV-2 infection who were admitted to the "ASST Bergamo Ovest" hospital between February 21 and May 31, 2020.
A total of seven hundred twenty-three inpatients met the eligible criteria and were included in the study cohort. Among the inpatients who survived, the average hospital length of stay was more than two weeks, with some lasting up to three months. Among the 281 non-survivors, death occurred in 50% within five days. Survivors were those whose first aid operators recorded higher oxygen saturation levels at home. The request for first aid assistance came more than one week after symptom onset, within three days in 10% of cases.
In similar future scenarios, based on our data, if we aim to enhance the survival rate, we need to improve the territorial healthcare assistance and admit to hospitals only those patients who are at risk of severe illness requiring specialized and urgent interventions within two, three, or, at most, five days from the onset of symptoms. This implies that the crucial factor is, has been, and will be the ability of a healthcare system to react promptly in its entirety within a few days.</description><subject>Age</subject><subject>Biomarkers</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 vaccines</subject><subject>Data collection</subject><subject>Development and progression</subject><subject>Disease transmission</subject><subject>Earthquakes</subject><subject>Emergency medical care</subject><subject>Epidemics</subject><subject>Epidemiology</subject><subject>Ethics</subject><subject>Evaluation</subject><subject>First aid</subject><subject>First aid in illness and injury</subject><subject>Forecasts and trends</subject><subject>Health care</subject><subject>Health care reform</subject><subject>Hospital patients</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Infection</subject><subject>Intensive care</subject><subject>Italy</subject><subject>Italy - epidemiology</subject><subject>Kinases</subject><subject>Laboratories</subject><subject>Oxygen content</subject><subject>Oxygen saturation</subject><subject>Pandemics</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Public health</subject><subject>Retrospective Studies</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Software</subject><subject>Survival</subject><subject>Viral diseases</subject><issn>1471-2334</issn><issn>1471-2334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkttu1DAQhiMEoqXwAlwgS9yA1BSfkti9QWWhsFKllTj01vL6kHWVxMH2LpSH4VlxdkvpIi5QFNmefPNPZvwXxVMETxBi9auIMGt4CTEtIYeElvRecYhog0pMCL1_Z39QPIrxCkLUMMwfFgckLw3G9LD4ee5CTGC2uJy_LREH3-TGADeAtDJgDH7jBmWAt-CNCa3s_TGYJ9ldnwIzOm165zvfOiU7IAcNVOeG7UGtZJAqmeBicioeA79OyvdmS_VykK3pzZAm3amO3f7CysfRZXH3w2gwyuQyER8XD6zsonlysx4VX87ffZ59KC8W7-ezs4tSVYykUslKVtxqYlWlamKXsmqwVbpmhlptl_mtK8qMoZohw5YYk1opgnIGVhQxclTMd7rayysxBtfLcC28dGIb8KEVMuReOiM4k5ZZjSG0Na1QldUgYVLzuqFYc5y1Xu-0xvWyN1rlPoLs9kT3vwxuJVq_EQjmayGIZoUXNwrBf12bmETvojJdJwfj11FgjhFCVYOmYs__Qq_8Ogx5VhNVVayBBP2hWpk7cIP1ubCaRMVZtgTiDeM8Uyf_oPIz3bTyg7Eux_cSXu4lZCaZ76mV6xjF_NPH_2cXl_ss3rEq-BiDsbfDQ1BM1hc764tsfbG1vpiG9uzu2G9Tfnud_AK8bf6_</recordid><startdate>20240131</startdate><enddate>20240131</enddate><creator>Donida, Bianca Maria</creator><creator>Pirola, Flavia Simonetta</creator><creator>Opizzi, Roberto</creator><creator>Assembergs, Peter</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240131</creationdate><title>First COVID-19 wave in the province of Bergamo, Italy: epidemiological and clinical characteristics, outcome and management of the first hospitalized patients</title><author>Donida, Bianca Maria ; Pirola, Flavia Simonetta ; Opizzi, Roberto ; Assembergs, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c583t-ca5a59fd3fc5c63fba572fcd68e4fdfbfdf6548ee4d81e8b2236cc31fd32c4183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Age</topic><topic>Biomarkers</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 vaccines</topic><topic>Data collection</topic><topic>Development and progression</topic><topic>Disease transmission</topic><topic>Earthquakes</topic><topic>Emergency medical care</topic><topic>Epidemics</topic><topic>Epidemiology</topic><topic>Ethics</topic><topic>Evaluation</topic><topic>First aid</topic><topic>First aid in illness and injury</topic><topic>Forecasts and trends</topic><topic>Health care</topic><topic>Health care reform</topic><topic>Hospital patients</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Infection</topic><topic>Intensive care</topic><topic>Italy</topic><topic>Italy - epidemiology</topic><topic>Kinases</topic><topic>Laboratories</topic><topic>Oxygen content</topic><topic>Oxygen saturation</topic><topic>Pandemics</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Public health</topic><topic>Retrospective Studies</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Software</topic><topic>Survival</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Donida, Bianca Maria</creatorcontrib><creatorcontrib>Pirola, Flavia Simonetta</creatorcontrib><creatorcontrib>Opizzi, Roberto</creatorcontrib><creatorcontrib>Assembergs, Peter</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints (Gale)</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>BMC infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Donida, Bianca Maria</au><au>Pirola, Flavia Simonetta</au><au>Opizzi, Roberto</au><au>Assembergs, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>First COVID-19 wave in the province of Bergamo, Italy: epidemiological and clinical characteristics, outcome and management of the first hospitalized patients</atitle><jtitle>BMC infectious diseases</jtitle><addtitle>BMC Infect Dis</addtitle><date>2024-01-31</date><risdate>2024</risdate><volume>24</volume><issue>1</issue><spage>151</spage><epage>12</epage><pages>151-12</pages><artnum>151</artnum><issn>1471-2334</issn><eissn>1471-2334</eissn><abstract>Northern Italy was the first European country affected by the spread of the SARS-CoV-2, with the epicenter in the province of Bergamo.
This study aims to analyze the characteristics of patients who experienced more severe symptoms during the first wave of COVID-19 pandemic.
We retrospectively collected epidemiological and clinical data on patients with laboratory-confirmed wild-type SARS-CoV-2 infection who were admitted to the "ASST Bergamo Ovest" hospital between February 21 and May 31, 2020.
A total of seven hundred twenty-three inpatients met the eligible criteria and were included in the study cohort. Among the inpatients who survived, the average hospital length of stay was more than two weeks, with some lasting up to three months. Among the 281 non-survivors, death occurred in 50% within five days. Survivors were those whose first aid operators recorded higher oxygen saturation levels at home. The request for first aid assistance came more than one week after symptom onset, within three days in 10% of cases.
In similar future scenarios, based on our data, if we aim to enhance the survival rate, we need to improve the territorial healthcare assistance and admit to hospitals only those patients who are at risk of severe illness requiring specialized and urgent interventions within two, three, or, at most, five days from the onset of symptoms. This implies that the crucial factor is, has been, and will be the ability of a healthcare system to react promptly in its entirety within a few days.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>38297224</pmid><doi>10.1186/s12879-024-09034-4</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1471-2334 |
ispartof | BMC infectious diseases, 2024-01, Vol.24 (1), p.151-12, Article 151 |
issn | 1471-2334 1471-2334 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_98af8fd200f645158b2038ad96742d92 |
source | NCBI_PubMed Central(免费); Publicly Available Content (ProQuest) |
subjects | Age Biomarkers COVID-19 COVID-19 - epidemiology COVID-19 vaccines Data collection Development and progression Disease transmission Earthquakes Emergency medical care Epidemics Epidemiology Ethics Evaluation First aid First aid in illness and injury Forecasts and trends Health care Health care reform Hospital patients Hospitals Humans Hypoxia Infection Intensive care Italy Italy - epidemiology Kinases Laboratories Oxygen content Oxygen saturation Pandemics Patient outcomes Patients Prognosis Public health Retrospective Studies SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Software Survival Viral diseases |
title | First COVID-19 wave in the province of Bergamo, Italy: epidemiological and clinical characteristics, outcome and management of the first hospitalized patients |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A11%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=First%20COVID-19%20wave%20in%20the%20province%20of%20Bergamo,%20Italy:%20epidemiological%20and%20clinical%20characteristics,%20outcome%20and%20management%20of%20the%20first%20hospitalized%20patients&rft.jtitle=BMC%20infectious%20diseases&rft.au=Donida,%20Bianca%20Maria&rft.date=2024-01-31&rft.volume=24&rft.issue=1&rft.spage=151&rft.epage=12&rft.pages=151-12&rft.artnum=151&rft.issn=1471-2334&rft.eissn=1471-2334&rft_id=info:doi/10.1186/s12879-024-09034-4&rft_dat=%3Cgale_doaj_%3EA782197899%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c583t-ca5a59fd3fc5c63fba572fcd68e4fdfbfdf6548ee4d81e8b2236cc31fd32c4183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2925587031&rft_id=info:pmid/38297224&rft_galeid=A782197899&rfr_iscdi=true |